Received Oct 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Expired dose given; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 1-year-old patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) for prophylaxis. Co-suspect products included Flu unspecified (Influenza vaccine) for prophylaxis. On an unknown date, the patient received FluLaval 2024-2025 season and Influenza vaccine. On an unknown date, an unknown time after receiving FluLaval 2024-2025 season and Influenza vaccine, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-OCT-2025 The physician contacted through a field representative, requesting data after an expired dose was given to a 1 year old patient. Only Flulaval season 2024-2025 could be selected in the listing. The CRM is as follows: The patient also received expired flu vaccine. The reporter was trying to find out how long the patients need to wait before coming back in to receive in date flu vaccine. The vaccine administration facility was the same as primary reporter. The batch number was not provided upon follow up with the reporter.